Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.
J Microbiol Immunol Infect. 2020 Apr 03;:
Authors: Cheng CY, Lee YL, Chen CP, Lin YC, Liu CE, Liao CH, Cheng SH
An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1-10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding.
PMID: 32331982 [PubMed - as supplied by publisher]